Catalyst Wire Dossier Catalyst Wire Dossier

Farnesyl Protein Transferase Inhibitor (FPTI)

· Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Farnesyl Protein Transferase Inhibitor (FPTI), covering 2015-02-18 to 2015-06-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701) [Phase 1, Phase 2]

See pricing